Michelle Chen

President & CEO, Form Bio and Venture Advisor at Form Bio

Speaker

Michelle Chen, Ph.D. is a biotech CEO and industry leader with extensive experience in AI strategy, business and corporate development, M&A, investor relations, ventures, fundraising, and R&D. She currently serves as President, CEO and Board Member of Form Bio, the first spin-off from Colossal Biosciences, where she leads company’s efforts to harness AI for genetic medicine design, development and genome engineering applications. Prior to Form Bio, Michelle served as Chief Business Officer at Insilico Medicine where she led the company’s business growth by translating cutting-edge AI technologies into high-value drug discovery and platform partnerships—unlocking billions in potential revenue.

Throughout her career, Michelle has built a strong cross-functional track record spanning R&D, product management, operations, and commercial leadership. She has held executive positions at Roche, Merck, BioMarin, and Agilent Technologies, and has also served as an advisor to venture capital firms and startups. Michelle has led newco. formations, investor relations, executed numerous M&A, licensing transactions across the U.S., Europe, and Asia from both buy side and sell side.

Michelle earned her Ph.D. in Biochemistry from the University of Washington, conducted postdoctoral research at UC San Francisco, and completed Bioinformatics training at Stanford University.